9 febrero 2015
The drug Gleevec (imatinib mesylate) is well known not only for its effectiveness against chronic myeloid leukemia (CML) and acute lymphoblastic leukemia, but also for the story behinds its development. A similar drug might be able to tame some brain cancers, new research has shown.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/Yq-vbb3dUAc/150209170958.htm
